Researchers think the virus behind COVID-19 may have multiple ways into cells—which could help us understand how it behaves.

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.” ...

A new study published in the journal of The Lancet Infectious Diseases showed that an efficient substitute for current COVID-19 therapies is ensitrelvir, a once-daily oral SARS-CoV-2 ...

SARS-CoV-2 is a new kind of coronavirus that appeared suddenly in late 2019. The disease it causes, called COVID-19, is now showing signs that it's able to spread outside of its place of origin. This ...

By Tarun Sai Lomte New evidence from Indian patients shows that severe COVID-19 is associated with distinct mitochondrial ...

Millions of COVID-19-associated illnesses and outpatient visits as well as thousands of hospitalizations and deaths continued to occur annually in the United States from late 2022 through 2024, ...

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...

A new Northwestern Medicine study invited users to track their long COVID-19 symptoms over time through an interactive mobile app, which curbed tracking struggles for patients. “Your doctor is not ...